Related Experiment Video
Updated: May 30, 2025

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
Published on: January 4, 2019
Demographic, anthropometric and intrasubject variations affect platelet-rich plasma formulation
Luis García-Bordes1,2,3, Pedro Álvarez-Díaz1,2,3,4, Eduard Alentorn-Geli1,2,4
1Instituto Cugat, Hospital Quironsalud Barcelona Barcelona Spain.
Platelet-rich plasma (PRP) has higher platelet concentrations than blood, with variations influenced by age, sex, and BMI. Understanding these factors is key for personalized PRP therapy.
Area of Science:
- Orthopedics and Sports Medicine
- Regenerative Medicine
- Hematology
Background:
- Platelet-rich plasma (PRP) is increasingly used for musculoskeletal pathologies.
- Variability in PRP composition can affect therapeutic outcomes.
- Standardized characterization of PRP is essential for clinical application.
Purpose of the Study:
- To analyze inter- and intra-individual variations in platelet concentration between whole blood and PRP.
- To assess how demographic and anthropometric factors influence these concentrations.
- To evaluate PRP coding systems and intrasubject variability.
Main Methods:
- Retrospective analysis of 686 patients with musculoskeletal pathologies treated with PRP.
- Comparison of platelet counts in blood and PRP.
- Analysis of demographic data (age, sex, BMI) and PRP coding systems.
Main Results:
- PRP showed significantly higher platelet concentrations than blood (378 vs. 222 × 10^3/µL).
- Younger age correlated with higher platelet counts in both blood and PRP.
- Higher platelet ratios were observed in males and individuals with higher BMI; intrasubject variability was greater in PRP than in blood.
Conclusions:
- Age, gender, BMI, and intrasubject variations significantly impact PRP formulation.
- These variables are crucial for developing predictable, personalized, and effective PRP therapeutic strategies.
More Related Videos
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017